155 related articles for article (PubMed ID: 28940393)
1. Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis.
Ye L; Wang W; Ospina NS; Jiang L; Christakis I; Lu J; Zhou Y; Zhu W; Cao Y; Wang S; Perrier ND; Young WF; Ning G; Wang W
Clin Endocrinol (Oxf); 2017 Dec; 87(6):706-716. PubMed ID: 28940393
[TBL] [Abstract][Full Text] [Related]
2. Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions.
Sakurai A; Imai T; Kikumori T; Horiuchi K; Okamoto T; Uchino S; Kosugi S; Suzuki S; Suyama K; Yamazaki M; Sato A;
Clin Endocrinol (Oxf); 2013 Feb; 78(2):248-54. PubMed ID: 22690831
[TBL] [Abstract][Full Text] [Related]
3. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).
Goudet P; Murat A; Cardot-Bauters C; Emy P; Baudin E; du Boullay Choplin H; Chapuis Y; Kraimps JL; Sadoul JL; Tabarin A; Vergès B; Carnaille B; Niccoli-Sire P; Costa A; Calender A;
World J Surg; 2009 Jun; 33(6):1197-207. PubMed ID: 19294466
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
5. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
6. Thymic carcinoids in multiple endocrine neoplasia type 1.
Teh BT; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
Ann Surg; 1998 Jul; 228(1):99-105. PubMed ID: 9671073
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study.
Chiloiro S; Lanza F; Bianchi A; Schinzari G; Brizi MG; Giampietro A; Rufini V; Inzani F; Giordano A; Rindi G; Pontecorvi A; De Marinis L
Endocrine; 2018 May; 60(2):362-367. PubMed ID: 28567607
[TBL] [Abstract][Full Text] [Related]
8. Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients.
de Laat JM; Pieterman CR; van den Broek MF; Twisk JW; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2014 Sep; 99(9):3325-33. PubMed ID: 24915123
[TBL] [Abstract][Full Text] [Related]
9. [Neuroendocrine neoplasms of the mediastinum].
Brcic L; Heidinger M; Popper H
Pathologe; 2016 Sep; 37(5):434-40. PubMed ID: 27507161
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center.
Christakis I; Qiu W; Silva Figueroa AM; Hyde S; Cote GJ; Busaidy NL; Williams M; Grubbs E; Lee JE; Perrier ND
Horm Cancer; 2016 Aug; 7(4):279-87. PubMed ID: 27311764
[TBL] [Abstract][Full Text] [Related]
11. The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group.
van den Broek MFM; de Laat JM; van Leeuwaarde RS; van de Ven AC; de Herder WW; Dekkers OM; Drent ML; Kerstens MN; Bisschop PH; Havekes B; Hackeng WM; Brosens LAA; Vriens MR; Buikhuisen WA; Valk GD
J Clin Endocrinol Metab; 2021 Jan; 106(2):e1014-e1027. PubMed ID: 33135721
[TBL] [Abstract][Full Text] [Related]
12. PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.
Conemans EB; Nell S; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Vriens MR; Valk GD
Endocr Pract; 2017 Jun; 23(6):641-648. PubMed ID: 28225311
[TBL] [Abstract][Full Text] [Related]
13. Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
Yliaska I; Tokola H; Ebeling T; Kuismin O; Ukkola O; Koivikko ML; Lesonen T; Rimpiläinen J; Felin T; Ryhänen E; Metso S; Schalin-Jäntti C; Salmela P
Endocrine; 2022 Sep; 77(3):527-537. PubMed ID: 35696052
[TBL] [Abstract][Full Text] [Related]
14. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
[TBL] [Abstract][Full Text] [Related]
15. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
[TBL] [Abstract][Full Text] [Related]
16. The future: surgical advances in MEN1 therapeutic approaches and management strategies.
Sadowski SM; Cadiot G; Dansin E; Goudet P; Triponez F
Endocr Relat Cancer; 2017 Oct; 24(10):T243-T260. PubMed ID: 28811298
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1.
Teh BT; McArdle J; Chan SP; Menon J; Hartley L; Pullan P; Ho J; Khir A; Wilkinson S; Larsson C; Cameron D; Shepherd J
Medicine (Baltimore); 1997 Jan; 76(1):21-9. PubMed ID: 9064485
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
19. Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors.
Faggiano A; Fazzalari B; Mikovic N; Russo F; Zamponi V; Mazzilli R; Guarnieri V; Piane M; Visco V; Petrucci S
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761922
[TBL] [Abstract][Full Text] [Related]
20. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
